Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Ru-106 Eye Applicators

NHS Greater Glasgow and Clyde

This public procurement record has 1 release in its history.

Award

11 Aug 2026 at 01:00

OJEU - F15 - Voluntary Ex Ante Transparency Notice
Summary of the contracting process

NHS Greater Glasgow and Clyde is buying radioactive ruthenium-106 (Ru-106) ophthalmic eye applicators and associated technical support for specialist ocular brachytherapy treatments within NHS Scotland. The applicators are ophthalmic brachytherapy plaques used to treat uveal melanoma, retinoblastoma and other ocular tumours. Their limited-range beta radiation is intended to deliver high doses to tumours while sparing sensitive eye structures. The goods will be delivered to the Beatson West of Scotland Cancer Centre (Beatson WOSCC). This is primarily a specialist medical goods requirement, classified under CPV 33151000 for radioactive products and related medical equipment. The buyer is NHS Greater Glasgow and Clyde, with the procurement supporting its clinical service and continued patient treatment.

The procurement has been awarded and the tender is complete. NHS Greater Glasgow and Clyde used a limited procedure without prior publication of a competition, relying on technical exclusivity because the required products were considered available only from Eckert & Ziegler BEBIG Ltd, with no reasonable alternative or substitute. The contract was signed on 4 August 2026 with Eckert & Ziegler BEBIG Ltd for £200,000 over 36 months, excluding VAT. The requirement covers one lot and approximately six Ru-106 eye applicators to be purchased and returned per year. A framework agreement technique is recorded. The award basis was the supplier’s ability to provide the clinically approved applicators needed to maintain specialist brachytherapy services.

This award indicates a narrowly specialised market for suppliers able to manufacture or supply radioactive Ru-106 ophthalmic applicators for ocular brachytherapy, together with responsive technical support. A credible competitor for a future requirement would need products suitable for treating ocular tumours, with clinically approved specifications and dependable handling, positioning, supply, return and support arrangements. The requirement also points to the need for sufficient capacity to provide a small but recurring volume of applicators for a specialist NHS cancer service, while meeting the technical and regulatory demands associated with radioactive medical products. Relevant experience in ophthalmic brachytherapy, established clinical-service support and the ability to offer a safe alternative to the incumbent’s product would be important commercial strengths.

How relevant is this notice?

Notice Information

Notice Title

Ru-106 Eye Applicators

Notice Description

NHS Greater Glasgow and Clyde intends to purchase Ru-106 Eye Applicators from Eckert & Ziegler for specialist ocular brachytherapy treatments delivered within NHS Scotland. The purchase includes the supply of radioactive Ru-106 ophthalmic applicators and associated technical support services as required by the clinical service.

Lot Information

Lot 1

Ru-106 eye applicators are ophthalmic brachytherapy plaques used primarily for treating uveal melanoma, retinoblastoma, and other ocular tumors. They consist of a thin film of Ru-106 beta-emitting isotope, encapsulated in pure silver sheets, with a total thickness of only 1 mm, making them easy to handle and position on the eye surface. The beta radiation has a limited range, allowing high doses to tumors up to 5 mm in thickness while sparing sensitive structures like the optic disc and fovea.. Approximately six (6) Ru-106 Eye Applicators required to be purchased and returned per year, this contract will cover a 36 month period

Procurement Information

In order to award this contract compliantly, NHSGGC will follow Regulation 33 (b) where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons (ii) competition is absent for technical reasons. The contract will support the continued provision of specialist brachytherapy services and ensure the ongoing availability of clinically approved applicators required for patient treatment. The estimated contract value is 200,000 GBP excluding VAT over a period of 3 years. The proposed award is being made without prior competition as the required products can only be supplied by the named contractor and no reasonable alternative or substitute exists.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000839176
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG562106
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
OJEU - F15 - Voluntary Ex Ante Transparency Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33151000 - Radiotherapy devices and supplies

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£200,000 £100K-£500K

Notice Dates

Publication Date
11 Aug 20262 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
4 Aug 20263 weeks ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS Greater Glasgow and Clyde
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
GLASGOW
Postcode
G4 0SF
Postcode Area
Glasgow
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM3 West Central Scotland
Small Region (ITL 3)
TLM32 Glasgow City
Delivery Location
TLM82 Glasgow City
Local Authority
Glasgow City
Electoral Ward
Dennistoun
Westminster Constituency
Glasgow North East

Supplier Information

Number of Suppliers
1
Supplier Name

Eckert & Ziegler BEBIG Ltd.

Further Information

Notice Documents

  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG562106
    Ru-106 Eye Applicators - NHS Greater Glasgow and Clyde intends to purchase Ru-106 Eye Applicators from Eckert & Ziegler for specialist ocular brachytherapy treatments delivered within NHS Scotland. The purchase includes the supply of radioactive Ru-106 ophthalmic applicators and associated technical support services as required by the clinical service.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...